Mental disorder due to a general medical condition
(UMLS:C0853895)
- UMLS ID:
- C0853895
- MeSH ID:
- N/A
Synonym(s)
1.
Mental disorder due to a general medical condition
2.
Mental Disorder Due to a General Medical Condition
3.
Mental Disorders due to General Medical Conditions
4.
disorder; mental, due to general medical condition
5.
mental; disorder, due to general medical condition
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | rofecoxib | FAERS: 9 | OFFSIDES US FAERS | |
| 2 | Tacrolimus | FAERS: 4 | US FAERS | |
| 3 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 2 | US FAERS | |
| 4 | Clozapine | FAERS: 2 | US FAERS | |
| 5 | Daunorubicin | FAERS: 2 | US FAERS | |
| 6 | Ertapenem | FAERS: 2 | US FAERS | |
| 7 | Levetiracetam | FAERS: 2 | US FAERS | |
| 8 | Pregabalin | FAERS: 2 | US FAERS | |
| 9 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 10 | Voriconazole | FAERS: 2 | US FAERS | |
| 11 | alvimopan | FAERS: 2 | US FAERS | |
| 12 | ziprasidone | FAERS: 2 | US FAERS | |
| 13 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 14 | Abiraterone Acetate | FAERS: 1 | US FAERS | |
| 15 | Acetaminophen | FAERS: 1 | US FAERS | |
| 16 | Clonazepam | FAERS: 1 | OFFSIDES US FAERS | |
| 17 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 18 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 19 | Isotretinoin | FAERS: 1 | US FAERS | |
| 20 | Ivosidenib | FAERS: 1 | US FAERS | |
| 21 | Levofloxacin | FAERS: 1 | US FAERS | |
| 22 | MDV 3100 | FAERS: 1 | US FAERS | |
| 23 | Methadone | FAERS: 1 | US FAERS | |
| 24 | Methotrexate | FAERS: 1 | US FAERS | |
| 25 | NuvaRing | FAERS: 1 | US FAERS | |
| 26 | Olanzapine | FAERS: 1 | OFFSIDES US FAERS | |
| 27 | Prednisone | FAERS: 1 | US FAERS | |
| 28 | Propofol | FAERS: 1 | US FAERS | |
| 29 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 30 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 31 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 32 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 33 | Sorafenib | FAERS: 1 | US FAERS | |
| 34 | Sunitinib | FAERS: 1 | US FAERS | |
| 35 | Telmisartan | FAERS: 1 | US FAERS | |
| 36 | Thalidomide | FAERS: 1 | US FAERS | |
| 37 | Zonisamide | FAERS: 1 | US FAERS | |
| 38 | delta-hexachlorocyclohexane | FAERS: 1 | US FAERS | |
| 39 | etonogestrel | FAERS: 1 | US FAERS | |
| 40 | oxybutynin | FAERS: 1 | US FAERS | |
| 41 | valdecoxib | FAERS: 1 | US FAERS | |
| 42 | Acetylcysteine | OFFSIDES | ||
| 43 | Beclomethasone | OFFSIDES | ||
| 44 | Bisacodyl | OFFSIDES | ||
| 45 | Buprenorphine | OFFSIDES | ||
| 46 | Butorphanol | OFFSIDES | ||
| 47 | Calcium Carbonate | OFFSIDES | ||
| 48 | Captopril | OFFSIDES | ||
| 49 | Carvedilol | OFFSIDES | ||
| 50 | Cefuroxime | OFFSIDES | ||
| 51 | Chlorhexidine | OFFSIDES | ||
| 52 | Cimetidine | SIDER | ||
| 53 | Cocaine | OFFSIDES | ||
| 54 | Dextropropoxyphene | OFFSIDES | ||
| 55 | Doxepin | OFFSIDES | ||
| 56 | Ertapenem | OFFSIDES | ||
| 57 | Etoricoxib | OFFSIDES | ||
| 58 | Ezetimibe | OFFSIDES | ||
| 59 | Fluorouracil | OFFSIDES | ||
| 60 | Gentamicins | SIDER | ||
| 61 | Glipizide | OFFSIDES | ||
| 62 | Haloperidol | OFFSIDES | ||
| 63 | Heroin | OFFSIDES | ||
| 64 | Ibuprofen | OFFSIDES | ||
| 65 | Lactulose | OFFSIDES | ||
| 66 | Lamotrigine | OFFSIDES | ||
| 67 | Leucovorin | OFFSIDES | ||
| 68 | Lisuride | SIDER | ||
| 69 | Lithium | SIDER | ||
| 70 | Mannitol | OFFSIDES | ||
| 71 | Paroxetine | OFFSIDES | ||
| 72 | Phenprocoumon | OFFSIDES | ||
| 73 | Ramipril | OFFSIDES | ||
| 74 | Ribavirin | OFFSIDES | ||
| 75 | Sunitinib | OFFSIDES | ||
| 76 | Trimipramine | OFFSIDES | ||
| 77 | chlorhexidine gluconate | OFFSIDES | ||
| 78 | iopromide | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.